Craig Sweeney, DO
Pain Medicine · Great Falls, MTNPI 1275761348
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Nevro Corp. at 33.4% of the total. Reporting peaked in 2019 at $377 and has fallen 60.4% since, to $149 in 2025.
Across 24 payments — averaging $44.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$359
- Boston Scientific$225
- Pacira Pharmaceuticals Incorporated$209
- Abbott$155
- Mindray DS USA, Inc.$31
- Bioventus LLC$28
- plus $70 from 4 others
What the payments were for
- Food & beverage$1,078100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 8 | $359 |
| Boston Scientific | 6 | $225 |
| Pacira Pharmaceuticals Incorporated | 2 | $209 |
| Abbott | 2 | $155 |
| Mindray DS USA, Inc. | 1 | $31 |
| Bioventus LLC | 1 | $28 |
| Biodelivery Sciences International, Inc. | 1 | $21 |
| Stimwave Technologies Incorporated | 1 | $21 |
| Avanos Medical | 1 | $17 |
| Werfen USA LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pain medicine providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 53 | $12,441 |
| Pregabalin | 495 | $7,517 |
| Gabapentin | 345 | $4,734 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 169 | $3,846 |
| FingolimodFingolimod Hcl | 12 | $3,500 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $3,186 |
| Tramadol Hcl | 336 | $2,361 |
| Celecoxib | 136 | $2,232 |
| Tramadol Hcl ErTramadol Hcl | 24 | $1,198 |
| Meloxicam | 192 | $947 |
| Tizanidine Hcl | 113 | $913 |
| Diclofenac Sodium | 34 | $912 |
| Duloxetine Hcl | 65 | $830 |
| Lidocaine | 11 | $642 |
| Nabumetone | 34 | $315 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Great Falls
- Katrina LewisGreat Falls$6K
- S Dante OrienteGreat Falls$2K
- Jamal BalouchGreat Falls$156
- Timothy StrigenzBozeman$10K
- Patrick DanaherMissoula$6K
- Aaron CrossHelena$5K
- Anna ColesKalispell$3K
- Steven MartiniAnaconda$934
- Oscar HeymanMissoula$464
- Brett BenderMissoula$273
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.